Although the use of drug-eluting stents ( DESs ) in patients with coronary artery disease has contributed to a significant reduction in in-stent restenosis and repeat revascularization , treating diffuse long lesions using DESs remains challenging due to the high rates of in-stent restenosis and stent thrombosis .